-
RCH Solutions Expands Coverage with the Hiring of Industry Veteran Frank Iafrato
Feb 19, 2019, 13:08 PM by Michael CroftWAYNE, PA, UNITED STATES - Feb 19, 2019 - RCH Solutions (RCH), a global provider of computational science expertise for Life Sciences and Healthcare firms of all sizes, announces the hiring of Frank Iafrato as Director of Sales and Business DevelopmentFull story -
Empire Genomics Appoints New Leadership and Relocates Headquarters to Support Growing Demand from Clinical Laboratories Around the World
Feb 19, 2019, 09:36 AM by Michael CroftWILLIAMSVILLE, NY, UNITED STATES - Feb 19, 2019 - Empire Genomics Inc., the premier global provider of clinical and custom labeled molecular probes, today announced the appointments of Andy Watson as Chief Executive Officer and Anthony Scarpello to Chief Commercialization Officer, and the opening of its new headquarters in Williamsville, NYFull story -
Quanticate Appoints Paula Finch as Senior Vice President, Project Delivery
Feb 19, 2019, 08:24 AM by Michael CroftLONDON, UNITED KINGDOM - Feb 19, 2019 - Quanticate, a leading global data-focused clinical research organisation (CRO), has appointed of Paula Finch as senior vice president of project deliveryFull story -
Shimmer Launches Verisense™ Wearable Sensor Platform for Clinical Trials
Feb 19, 2019, 08:17 AM by Michael CroftCAMBRIDGE, MA, US - Feb 19, 2019 - Shimmer, a global leader in wearable technology for research applications, today announced the launch of Verisense, its next-generation wearable sensor platform designed from the ground up to meet the needs of clinical trial sponsors, sites and participantsFull story -
No Black Box: Securing Our Data Analytics
Feb 18, 2019, 14:15 PM by Michael CroftFull storyBio-IT World | Data scientists and lawyers have fundamentally different goals. A data scientist wants as much relevant data as possible. A lawyer wants to limit unauthorized use of the data. How do you create a symbiotic relationship? How do you mitigate the concerns of both? A company called Immuta is building a data management and permissions platform that will please both.
-
Karger Publishers Invests in the Biomedical Discovery Company Quertle
Feb 15, 2019, 15:20 PM by Michael CroftBASEL, SWITZERLAND - Feb 15, 2019 - At the beginning of 2019, Karger became a major shareholder in the award-winning company that has developed the first biomedical-specific AI Big Data Visual Analytics EnginexFull story -
IBM, Broad Institute Launch Initiative Using Genomics & AI To Predict Risk Of Cardiovascular Disease
Feb 14, 2019, 11:05 AM by Michael CroftFull storyBio-IT World News Brief | IBM Watson Health and the Broad Institute are expanding their partnership to help clinicians better predict the possibility of serious cardiovascular diseases.
-
Recipharm announces all its facilities are ready for EU serialisation
Feb 14, 2019, 05:19 AM by Michael CroftSTOCKHOLM, SWEDEN - Feb 14, 2019 - Recipharm, the contract development and manufacturing organisation (CDMO), today announced that all fifteen of its facilities outlined in its investment plan are now fully prepared for drug serialisation and have delivered serialised batches within Europe ahead of the February 9th deadlineFull story -
Data Is The Key Ingredient To Digital Transformation
Feb 13, 2019, 12:45 PM by Michael CroftFull storyBio-IT World Contributed Commentary | The pharmaceutical industry needs a data transformation before it can realize its digital transformation—and most companies recognize the urgency.
-
Chemspace and LabNetwork collaborate to extend access to chemical databases
Feb 13, 2019, 07:08 AM by Michael Croft, RIGA, LATVIA AND SHANGHAI, CHINA - Feb 13, 2019 - Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, today announced they have entered into a collaboration agreementFull story -
Victa Biotherapeutics Appoints Donald W. Kufe to Board of Directors
Feb 12, 2019, 09:11 AM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Feb 12, 2019 - HiFiBiO Therapeutics, a world leader in the discovery and development of therapeutic antibodies enabled by unique single-cell profiling and full immune repertoire screening, today announced Donald WFull story -
From Patient-Centric Technologies to Clinical Trial Supply Chain Management, CRF Bracket Moves Clinical Trials Forward at the 10th Annual SCOPE Summit
Feb 12, 2019, 09:06 AM by Michael CroftPLYMOUTH MEETING, PA - Feb 12, 2019 - Running a seamless clinical trial means improving not only data quality but also operational logistics and most importantly the patient experienceFull story -
FreeLIMS Launches New Version of its LIMS
Feb 12, 2019, 07:50 AM by Michael CroftSAN FRANCISCO, CA, US - Feb 12, 2019 - FreeLIMS announces the release of a new version of its free Laboratory Information Management System (LIMS), FreeLIMSFull story -
Recipharm appoints new Director of Business Management
Feb 12, 2019, 06:13 AM by Michael CroftSTOCKHOLM, SWEDEN - Feb 12, 2019 - Recipharm, the contract development and manufacturing organisation (CDMO), has appointed a new director of business management for the USA and Canada to accelerate growth in the regionFull story -
The Bioinformatics Infrastructure Congress launches in Boston, May 2019
Feb 11, 2019, 10:47 AM by Michael CroftBOSTON, MA - May 7, 2019 - Kisaco Research is delighted to announce the launch of the Bioinformatics Infrastructure Congress running in Boston on May 8-9th, 2019Full story -
Trump To Sign Executive Order Promoting Artificial Intelligence
Feb 11, 2019, 10:09 AM by Michael CroftThe New York Times | President Trump is expected to sign an executive order meant to spur the development and regulation of AI. But the order does not set aside additional funds for AI development, and officials provided few details on how it will track the progress of its new policies.Full story -
Clinical Genomics Insights In Hematological Malignancies Require Streamlined Bioinformatics Solutions
Feb 8, 2019, 11:25 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Next-generation sequencing has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors have set the foundation for genomics-guided precision medicine; but, for hematological malignancies, the path to precision medicine is a lot more complex.
-
The Pistoia Alliance Launches Next Phase of Blockchain Project to Develop Life Science R&D Use Cases
Feb 8, 2019, 11:01 AM by Michael CroftBOSTON, MA - Feb 8, 2019 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, is today launching the next phase of its blockchain projectFull story -
Certara Advances Global Initiative to Take Model-informed Precision Dosing (MIPD) Into the Clinic
Feb 7, 2019, 13:16 PM by Michael CroftPRINCETON, NJ - Feb 7, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced its latest advances in bringing model-informed precision dosing (MIPD) to the point of careFull story -
Clinithink secures growth-equity investment to fuel growth
Feb 7, 2019, 11:07 AM by Michael CroftLONDON, UNITED KINGDOM - Feb 7, 2019 - Leading healthcare technology investors partner with Clinithink to unlock the potential of unstructured data to inform treatment decisions, identify candidates for clinical trials, and ensure appropriate reimbursement Clinithink, which offers healthcare and life sciences organizations powerful clinical data insights through its patented CLiX natural language processing (NLP) platform, has secured a growth-equity investment from TT Capital Partners (TTCP) and the MSD Global Health Innovation Fund (GHI) to expand its global footprint and continue to broaden its service offeringFull story